<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>JCD &#187; JCD &#8211; Vol 1 &#8211; Issue 1</title>
	<atom:link href="http://jcdonline.in/category/jcd-vol-1-issue-1/feed/" rel="self" type="application/rss+xml" />
	<link>http://jcdonline.in</link>
	<description></description>
	<lastBuildDate>Mon, 26 Jul 2021 12:17:49 +0000</lastBuildDate>
	<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=3.9.36</generator>
	<item>
		<title>JCD &#8211; Vol 1 &#8211; Issue 1</title>
		<link>http://jcdonline.in/2015/02/jcd-volume-1-issue1/</link>
		<comments>http://jcdonline.in/2015/02/jcd-volume-1-issue1/#comments</comments>
		<pubDate>Mon, 16 Feb 2015 16:11:33 +0000</pubDate>
		<dc:creator><![CDATA[jcd]]></dc:creator>
				<category><![CDATA[JCD - Vol 1 - Issue 1]]></category>

		<guid isPermaLink="false">http://jcdonline.in/?p=380</guid>
		<description><![CDATA[<p>Hyponatremia in Diabetes Saptarshi Mukhopadhyay, Tanmoy Chattopadhyay Diabetes mellitus is rapidly emerging as an important cause of mortality and morbidity in developing countries. It is an established risk factor for coronary heart disease, stroke, and end-stage renal disease. Diabetic nephropathy is one of the complications of diabetes mellitus that ultimately leads to renal failure, and [&#8230;]</p>
<p>The post <a rel="nofollow" href="http://jcdonline.in/2015/02/jcd-volume-1-issue1/">JCD &#8211; Vol 1 &#8211; Issue 1</a> appeared first on <a rel="nofollow" href="http://jcdonline.in">JCD</a>.</p>
]]></description>
				<content:encoded><![CDATA[<div class="panel-grid" id="pg-380-0" ><div class="panel-grid-cell" id="pgc-380-0-0" ><div class="panel widget widget_black-studio-tinymce panel-first-child panel-last-child" id="panel-380-0-0-0">			<div class="textwidget"><p><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt;"><span style="font-weight: inherit; color: #3366ff;"><strong style="font-style: inherit;"><a href="http://jcdonline.in/wp-content/uploads/2014/06/JCD_cover-e1408106005145.jpg"><img class="alignleft wp-image-10 size-medium" src="http://jcdonline.in/wp-content/uploads/2014/06/JCD_cover-237x300.jpg" alt="JCD_cover" width="237" height="300" /></a>Hyponatremia in Diabetes</strong></span></span></p>
<p><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Saptarshi Mukhopadhyay, Tan<span style="font-weight: inherit;">moy Chattopadhyay</span></span></p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;">Diabetes mellitus is rapidly emerging as an important cause of mortality and morbidity in developing countries. It is an established risk factor for coronary heart disease, stroke, and end-stage renal disease. Diabetic nephropathy is one of the complications of diabetes mellitus that ultimately leads to renal failure, and renal failure is a cause of electrolyte imbalance among hospitalized diabetic patients; other causes are diarrhea, vomiting, diuretic use, and chronic laxative use.</span></p>
<p><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt; color: #ff0000;"><a title="Hyponatremia in Diabetes" href="http://jcdonline.in/wp-content/uploads/2014/06/Pages-from-ACD_layout_20140602-1.pdf" target="_blank"><span style="color: #ff0000;">Read Full Article</span></a></span></p>
<p> </p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;"><strong style="font-style: inherit;"><span style="font-weight: inherit; color: #3366ff;">Cognitive Dysfunction in Patients with Diabetes</span></strong></span></p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;">Jotideb Mukhopadhyay</span></p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;">The incidence of type 2 diabetes mellitus (T2DM) has risen, and this trend is likely to continue. Recent advances suggest that T2DM is a risk factor for cognitive decline. We are now encountering novel complications of T2DM, namely cognitive dysfunction and dementia. Although the treatment strategy for diabetic patients with neurocognitive dysfunction has received a great deal of attention, the appropriate level of glycemic control for the prevention of the development and/or progression of cognitive decline in elderly diabetic patients remains to be elucidated.</span></p>
<p><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt; color: #ff0000;"><a title="Cognitive Dysfunction in Patients with Diabetes" href="http://jcdonline.in/wp-content/uploads/2014/06/Pages-from-ACD_layout_20140602-2.pdf" target="_blank"><span style="color: #ff0000;">Read More</span></a></span></p>
<p> </p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;"><span style="font-weight: inherit; color: #3366ff;"><strong style="font-style: inherit;">Male Hypogonadism and Type 2 Diabetes Mellitus</strong></span></span></p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;">Saumik Datta</span></p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;">Age dependant decrease of testosterone levels leads in many men to hypogonadism called as late-onset hypogonadism. Morbidity and mortality of men with subnormal testosterone levels is higher than that of men sufficiently supplied with androgens. Cardiovascular diseases, obesity or diabetes take often part in these events.</span></p>
<p><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt; color: #ff0000;"><a title="Male Hypogonadism and Type 2 Diabetes Mellitus" href="http://jcdonline.in/wp-content/uploads/2014/06/Pages-from-ACD_layout_20140602-2.pdf" target="_blank"><span style="color: #ff0000;">Read Full Article</span></a></span></p>
<p> </p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;"><span style="font-weight: inherit; color: #3366ff;"><a style="font-weight: inherit; font-style: inherit; color: #7ab80e;" href="http://jcdonline.in/cerebrovascular-diseases-diabetes/" target="_blank"><span style="color: #3366ff;"><strong style="font-style: inherit;">C</strong></span></a><strong style="font-style: inherit;">erebrovascular Diseases in Diabetes</strong></span></span></p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;">Samar Banerjee</span></p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;">Ischemic stroke and vascular cognitive impairment are leading causes of long-term disability and constitute a major public health burden and a significant economic burden to health systems. An increasing body of evidence demonstrates that disorders of glucose metabolism including diabetes, and the intermediate states of impaired fasting glucose and impaired glucose tolerance, as well as the cluster of risk factors known as the metabolic syndrome, are important risk factors for ischemic stroke.</span></p>
<p><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt; color: #ff0000;"><a title="Cerebrovascular Diseases in Diabetes" href="http://jcdonline.in/wp-content/uploads/2014/06/Pages-from-ACD_layout_20140602-4.pdf" target="_blank"><span style="color: #ff0000;">Read Full Article</span></a></span></p>
<p> </p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;"><span style="font-weight: inherit;"><span style="color: #3366ff;"><strong style="font-style: inherit;">A Case of Type 2 Diabetes Presenting With Charcot Joint at Diagnosis</strong></span></span></span></p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;">Debmalya Sanyal</span></p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;">Neuropathic joints, often called Charcot joints, are caused by loss of sensation in the joint to the extent that they are damaged and disrupted. The damage and disruption is often not grave and early diagnosis on clinical examination and X-ray is often missed since the joints, although swollen, are painless.</span></p>
<p><span style="color: #ff0000;"><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt;"><a title="A Case of Type 2 Diabetes Presenting with Charcot Joint at Diagnosis" href="http://jcdonline.in/wp-content/uploads/2014/06/Pages-from-ACD_layout_20140602-5.pdf" target="_blank"><span style="color: #ff0000;">Read Full Article</span></a></span><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt;"><a title="A Case of Type 2 Diabetes Presenting with Charcot Joint at Diagnosis" href="http://jcdonline.in/wp-content/uploads/2014/06/Pages-from-ACD_layout_20140602-5.pdf" target="_blank"><span style="color: #ff0000;"> </span></a></span></span></p>
<p> </p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;"><span style="font-weight: inherit; color: #3366ff;"><strong style="font-style: inherit;">Current Progress with Basal Insulin Analogues</strong></span></span></p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;">Awadhesh Kumar Singh</span></p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;">Conventional basal insulin preparations have to be resuspended prior to injection and have low therapeutic efficacy and drawbacks like nocturnal hypoglycemia. There is evidence supporting improved pharmacokinetic and pharmacodynamic profiles of basal insulin analogues, glargine and detemir as compared with NPH.</span></p>
<p><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt; color: #ff0000;"><a title="Current Process with Basal Insulin Analogues" href="http://jcdonline.in/wp-content/uploads/2014/06/Pages-from-ACD_layout_20140602-6.pdf" target="_blank"><span style="color: #ff0000;">Read Full Article</span></a></span></p>
<p> </p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;"><span style="font-weight: inherit; color: #3366ff;"><strong style="font-style: inherit;">Journal Watch</strong></span></span></p>
<p><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt; color: #ff0000;"><a title="Journal Watch" href="http://jcdonline.in/wp-content/uploads/2014/06/Pages-from-ACD_layout_20140602-7.pdf" target="_blank"><span style="color: #ff0000;">Read Full Article</span></a></span></p>
<p> </p>
<p><span style="font-weight: inherit; font-family: arial, helvetica, sans-serif; font-size: 12pt;"><span style="font-weight: inherit; color: #3366ff;"><strong style="font-style: inherit;">Quiz</strong></span></span></p></div>
</div></div></div><p>The post <a rel="nofollow" href="http://jcdonline.in/2015/02/jcd-volume-1-issue1/">JCD &#8211; Vol 1 &#8211; Issue 1</a> appeared first on <a rel="nofollow" href="http://jcdonline.in">JCD</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://jcdonline.in/2015/02/jcd-volume-1-issue1/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
